Heart Health Benefits of Ozempic and Similar Drugs

Medications like Ozempic and Wegovy, widely known for their effectiveness in weight loss, may also provide powerful heart health benefits. These drugs, part of a class called semaglutides, are showing promise in reducing the risk of heart attacks, strokes, and other serious cardiovascular complications—even in people who don’t lose weight.

Research Findings
Two groundbreaking studies, presented at the 2024 European Congress on Obesity, followed over 17,000 overweight or obese adults without diabetes who received weekly semaglutide injections. The British Heart Foundation reports that participants achieved an average weight loss of 10% after four years, regardless of their age or body size.

More importantly, the benefits extended beyond weight loss:

• Participants were significantly less likely to experience life-threatening heart events like heart attacks or strokes.
• Even those who didn’t lose weight still saw reduced cardiac risk, suggesting that semaglutides improve heart health by lowering blood sugar, reducing blood pressure, and combating inflammation in the heart.

Barriers to Access
Despite these promising findings, access to semaglutide medications remains limited in the U.S. Most insurers only cover these drugs for patients with diabetes or prediabetes, leaving many to pay out of pocket—at a staggering cost of $1,000 or more per month, according to GoodRx.

However, there may be hope on the horizon. A proposed rule by the Biden administration, announced in November 2024, could expand Medicare and Medicaid coverage for anti-obesity drugs starting in 2025. If approved, this reclassification of obesity drugs as treatment for chronic disease could make medications like Ozempic more accessible to millions.

A New Chapter in Heart Health
The discovery of heart health benefits beyond weight loss marks a significant milestone in cardiovascular care. While these medications offer new possibilities, their high costs and limited insurance coverage remain barriers for many. With potential policy changes on the horizon, this could change, bringing broader access to treatments that not only aid in weight loss but also protect the heart.